The coronavirus pandemic reset our expectations of what's possible. New medicines and vaccines are being developed at a previously unimaginable pace. Telemedicine has replaced the doctor’s office. Now, we’re starting to figure out how the world has been reshaped in the wake of Covid-19, pushing us to reexamine long-standing inequities in health care and make new discoveries at top speed.

As we work to navigate this new order, we invite you to join us — and some of the greatest minds in science and medicine — for our virtual 2020 STAT Summit, where we’ll answer the big question on everyone’s mind: What’s next?

Our speaker lineup includes:

• Behzad Aghazadeh, Ph.D., Managing Partner & Portfolio Manager, Avoro Capital Advisors
• Regina Barzilay, Ph.D., Delta Electronics Professor, Department of Electrical Engineering and Computer Science; Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology
• Angela M. Belcher, Ph.D., James Mason Crafts Professor of Biological Engineering and Materials Science, Massachusetts Institute of Technology
• Albert Bourla, DVM, Ph.D., Chairman and Chief Executive Officer, Pfizer
• Tony Coles, M.D., Executive Chairman & CEO, Cerevel Therapeutics, LLC
• Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases (NIAID)
• David Feinberg, M.D., Head of Google Health
• Sekar Kathiresan, M.D., Co-Founder and Chief Executive Officer, Verve Therapeutics
• Reshma Kewalramani, M.D., CEO and President, Vertex Pharmaceuticals
• Ted W. Love, M.D., President and Chief Executive Officer, Global Blood Therapeutics
• Michelle McMurry-Heath, M.D., Ph.D., President & CEO, Biotechnology Innovation Organization (BIO)
• Deval L. Patrick, Former Governor of Massachusetts; Founder & Chairman, TogetherFUND PAC
• Aviv Regev, Ph.D., Executive Vice President, Genentech Research and Early Development
• Jonathan Rothberg, Ph.D, Chairman of 4Catalyzer (Butterfly Network, Quantum-Si, AI Therapeutics, Hyperfine, Tesseract Health, EpilepsyCo, Homodeus)
• Anne Wojcicki, CEO and Co-Founder, 23andMe
• George D. Yancopoulos, M.D., Ph.D., Co-Founder, President, and Chief Scientific Officer, Regeneron

Visit our 2020 STAT Summit page for more a full speaker lineup and programming details.

TICKETS

There are two ways to access programming for this special event.

$300 Viewer Pass

• Limited access to the four-day program.
• View-only access to a livestream for the “main stage” programming. Those with a Viewer Pass will not have access to breakout sessions, and will not be able to participate in the Q&As.
• Participation in targeted 1:1 networking via the virtual event platform, Brella.
• Access to exclusive pre-recorded content from STAT, and all post-event recordings.
• Ability to browse virtual sponsor booths and network with representatives.

$600 Attendee Pass (By Invitation Only)

• Full access to the four-day program.
• The opportunity to attend all “main stage” programming including live interviews, keynotes, and panel discussions with featured speakers. This includes the ability to ask questions to featured speakers live during these sessions, via typed or call-in Q&A.
• Exclusive access to small group breakout sessions hosted by an event speaker and moderated by a STAT reporter. Attendees will be given the option to show their own audio and video during these sessions for real-time conversations and networking. These sessions will not be livestreamed.
• One STAT Summit welcome bag shipped directly to the attendee. (While supplies last, domestic shipping only.)
• Participation in targeted 1:1 networking via the virtual event platform, Brella.
• Access to exclusive pre recorded content from STAT and all post-event recordings.
• Ability to browse virtual sponsor booths and network with representatives.

Attendee Passes are sold out. You can still join us at the Summit with a Viewer Pass!

QUESTIONS?

Email us at subscribers@statnews.com or visit our Events Terms & Conditions.

A SPECIAL THANKS TO OUR PARTNERS: